Skip to main content
Top
Published in: Endocrine 3/2019

01-09-2019 | Insulins | Research Letter

Sweat and vitamin D status in congenital, lifetime, untreated GH deficiency

Authors: Cynthia S. Barros-Oliveira, Roberto Salvatori, Jéssica S. S. dos Santos, Paula F. C. Santos, Alécia A. Oliveira-Santos, Cindi G. Marinho, Elenilde G. Santos, Ângela C. G. B. Leal, Viviane C. Campos, Nayra P. Damascena, Carla R. P. Oliveira, Manuel H. Aguiar-Oliveira

Published in: Endocrine | Issue 3/2019

Login to get access

Abstract

Purpose

A reciprocal relationship exists between the skin and the GH/IGF-I axis. Skin produces both IGF- I and vitamin D, and GH and IGF-I exert several actions in the skin. Reduced sweating and altered phosphor-calcium homeostasis are occasionally reported in subjects with GH deficiency (GHD), mostly in the setting of hypopituitarism, therefore associated to other hormonal deficiencies. It is unclear whether these findings are due to GHD. The aim of this study was to assess skin function in subjects with isolated GHD (IGHD) due to a mutation in the GHRH receptor gene.

Methods

In a cross-sectional study we enrolled 20 IGHD and 20 local controls. Sweating (volume, conductivity and chloride content) was assessed by a 30 min pilocarpine iontophoresis test, using the Macroduct® Sweat Collection System. IGF-I, Insulin, PTH, 25-hydroxyvitamin D, C-reactive protein (CRP), CPK, glucose, calcium, phosphate, alkaline phosphatase, total proteins and fractions, urinary calcium, and insulin were measured. HOMA-IR was calculated.

Results

IGHD presented lower sweating, but normal vitamin D and phosphor-calcium homeostasis. Additionally, IGHD subjects presented lower HOMA-IR, higher CRP and reduced CPK.

Conclusion

Untreated IGHD cause reduction in sweating, but does not affect phosphor-calcium homeostasis.
Literature
1.
go back to reference C.C. Zoubolis, The human skin as a hormone target and an endocrine. Hormones 3(1), 9–26 (2004)CrossRef C.C. Zoubolis, The human skin as a hormone target and an endocrine. Hormones 3(1), 9–26 (2004)CrossRef
2.
go back to reference C. Kanaka-Gantenbein, C. Kogia, M.B. Abdel-Naser, G.P. Chrousos, Skin manifestations of growth hormone-induced diseases. Rev. Endocr. Metab. Disord. 17(3), 259–267 (2016)CrossRef C. Kanaka-Gantenbein, C. Kogia, M.B. Abdel-Naser, G.P. Chrousos, Skin manifestations of growth hormone-induced diseases. Rev. Endocr. Metab. Disord. 17(3), 259–267 (2016)CrossRef
3.
go back to reference M. Lange, J. Thulesen, U. Feldt-Rasmussen, N.E. Skakkebñk, N. Vahl, J.O. Jørgensen, J.S. Christiansen, S.S. Poulsen, S.B. Sneppen, A. Juul, Skin morphological changes in growth hormone deficiency and acromegaly. Eur. J. Endocrinol. 145(2), 147–153 (2001)CrossRef M. Lange, J. Thulesen, U. Feldt-Rasmussen, N.E. Skakkebñk, N. Vahl, J.O. Jørgensen, J.S. Christiansen, S.S. Poulsen, S.B. Sneppen, A. Juul, Skin morphological changes in growth hormone deficiency and acromegaly. Eur. J. Endocrinol. 145(2), 147–153 (2001)CrossRef
4.
go back to reference S.A. Pedersen, K. Welling, K.F. Michaelsen, J.O. Jørgensen, J.S. Christiansen, N.E. Skakkebaek, Reduced sweating in adults with growth hormone deficiency. Lancet 2(8664), 681–682 (1989)CrossRef S.A. Pedersen, K. Welling, K.F. Michaelsen, J.O. Jørgensen, J.S. Christiansen, N.E. Skakkebaek, Reduced sweating in adults with growth hormone deficiency. Lancet 2(8664), 681–682 (1989)CrossRef
5.
go back to reference K. Main, K.W. Kastrup, N.E. Skakkebaek, Reduced sweating in Laron’s dwarfism. Arch. Dis. Child. 65(12), 1380 (1990)CrossRef K. Main, K.W. Kastrup, N.E. Skakkebaek, Reduced sweating in Laron’s dwarfism. Arch. Dis. Child. 65(12), 1380 (1990)CrossRef
6.
go back to reference P. Ameri, A. Giusti, M. Boschetti, G. Murialdo, F. Minuto, D. Ferone, Interactions between vitamin D and IGF‐I: from physiology to clinical practice. Clin. Endocrinol. (Oxf.) 79(4), 457–463 (2013)CrossRef P. Ameri, A. Giusti, M. Boschetti, G. Murialdo, F. Minuto, D. Ferone, Interactions between vitamin D and IGF‐I: from physiology to clinical practice. Clin. Endocrinol. (Oxf.) 79(4), 457–463 (2013)CrossRef
7.
go back to reference E. Witkowska-Sędek, A. Kucharska, M. Rumińska, B. Pyrżak, Relationship between 25 (OH) D and IGF-I in children and adolescents with growth hormone deficiency. Adv. Exp. Med. Biol. 912, 43–49 (2016)CrossRef E. Witkowska-Sędek, A. Kucharska, M. Rumińska, B. Pyrżak, Relationship between 25 (OH) D and IGF-I in children and adolescents with growth hormone deficiency. Adv. Exp. Med. Biol. 912, 43–49 (2016)CrossRef
8.
go back to reference A. Ciresi, F. Cicciò, C. Giordano, High prevalence of hypovitaminosis D in Sicilian children affected by growth hormone deficiency and its improvement after 12 months of replacement treatment. J. Endocrinol. Invest. 37(7), 631–638 (2014)CrossRef A. Ciresi, F. Cicciò, C. Giordano, High prevalence of hypovitaminosis D in Sicilian children affected by growth hormone deficiency and its improvement after 12 months of replacement treatment. J. Endocrinol. Invest. 37(7), 631–638 (2014)CrossRef
9.
go back to reference R. Salvatori, C.Y. Hayashida, M.H. Aguiar-Oliveira, J.A. Phillips 3rd, A.H. Souza, R.G. Gondo, S.P. Toledo, M.M. Conceição, M. Prince, H.G. Maheeshwari, G. Baumann, M.A. Levine, Familial dwarfism due to a novel mutation of the growth hormone-releasing hormone receptor gene. J. Clin. Endocrinol. Metab. 84(3), 917–923 (1999)PubMed R. Salvatori, C.Y. Hayashida, M.H. Aguiar-Oliveira, J.A. Phillips 3rd, A.H. Souza, R.G. Gondo, S.P. Toledo, M.M. Conceição, M. Prince, H.G. Maheeshwari, G. Baumann, M.A. Levine, Familial dwarfism due to a novel mutation of the growth hormone-releasing hormone receptor gene. J. Clin. Endocrinol. Metab. 84(3), 917–923 (1999)PubMed
10.
go back to reference A.L. Andrade-Guimarães, M.H. Aguiar-Oliveira, R. Salvatori, V.O. Carvalho, F. Alvim-Pereira, C.R.A. Daniel, G.A.M. Brasileiro, A.A. Santana-Ribeiro, H.A. Santos-Carvalho, C.R.P. Oliveira, E.R. Vieira, M.B. Gois-Junior, Adult individuals with congenital, untreated, severe isolated growth hormone deficiency have satisfactory muscular function. Endocrine 63(1), 112–119 (2019)CrossRef A.L. Andrade-Guimarães, M.H. Aguiar-Oliveira, R. Salvatori, V.O. Carvalho, F. Alvim-Pereira, C.R.A. Daniel, G.A.M. Brasileiro, A.A. Santana-Ribeiro, H.A. Santos-Carvalho, C.R.P. Oliveira, E.R. Vieira, M.B. Gois-Junior, Adult individuals with congenital, untreated, severe isolated growth hormone deficiency have satisfactory muscular function. Endocrine 63(1), 112–119 (2019)CrossRef
11.
go back to reference M.H. Aguiar-Oliveira, A.H.O. Souza, C.R.P. Oliveira, V.C. Campos, L.A. Oliveira-Neto, R. Salvatori, Mechanisms in endocrinology: the multiple facets of GHRH/GH/IGF-I axis: lessons from lifetime, untreated, isolated GH deficiency due to a GHRH receptor gene mutation. Eur. J. Endocrinol. 177(2), R85–R97 (2017)CrossRef M.H. Aguiar-Oliveira, A.H.O. Souza, C.R.P. Oliveira, V.C. Campos, L.A. Oliveira-Neto, R. Salvatori, Mechanisms in endocrinology: the multiple facets of GHRH/GH/IGF-I axis: lessons from lifetime, untreated, isolated GH deficiency due to a GHRH receptor gene mutation. Eur. J. Endocrinol. 177(2), R85–R97 (2017)CrossRef
12.
go back to reference M.H. Aguiar-Oliveira, A. Bartke, Growth hormone deficiency: health and longevity. Endocr. Rev. 40(2), 575–601 (2019)CrossRef M.H. Aguiar-Oliveira, A. Bartke, Growth hormone deficiency: health and longevity. Endocr. Rev. 40(2), 575–601 (2019)CrossRef
13.
go back to reference C.G. Marinho, L.M. Mermejo, R. Salvatori, J.A. Junior Assirati, C.R.P. Oliveira, E.G. Santos, Â.C.G.B. Leal, C.S. Barros-Oliveira, N.P. Damascena, C.A. Lima, C.T. Farias, A.C. Moreira, M.H. Aguiar-Oliveira, Occurrence of neoplasms in individuals with congenital, severe GH deficiency from the Itabaianinha kindred. Growth Horm. IGF Res. 41(2018), 71–74 (2018)CrossRef C.G. Marinho, L.M. Mermejo, R. Salvatori, J.A. Junior Assirati, C.R.P. Oliveira, E.G. Santos, Â.C.G.B. Leal, C.S. Barros-Oliveira, N.P. Damascena, C.A. Lima, C.T. Farias, A.C. Moreira, M.H. Aguiar-Oliveira, Occurrence of neoplasms in individuals with congenital, severe GH deficiency from the Itabaianinha kindred. Growth Horm. IGF Res. 41(2018), 71–74 (2018)CrossRef
14.
go back to reference C.E.S. Ferreira, S.S. Maeda, M.C. Batista, M. Lazaretti-Castro, L.S. Vasconcellos, M. Madeira, L.M. Soares, V.Z.C. Borba, B.C.C. Silva, C.A. Moreira, Consensus – reference ranges of vitamin D [25(OH)D] from the Brazilian medical societies. Brazilian Society of Clinical Pathology/Laboratory Medicine (SBPC/ML) and Brazilian Society of Endocrinology and Metabolism (SBEM). J. Bras. Patol. Med Lab. 53(6), 377–381 (2017)CrossRef C.E.S. Ferreira, S.S. Maeda, M.C. Batista, M. Lazaretti-Castro, L.S. Vasconcellos, M. Madeira, L.M. Soares, V.Z.C. Borba, B.C.C. Silva, C.A. Moreira, Consensus – reference ranges of vitamin D [25(OH)D] from the Brazilian medical societies. Brazilian Society of Clinical Pathology/Laboratory Medicine (SBPC/ML) and Brazilian Society of Endocrinology and Metabolism (SBEM). J. Bras. Patol. Med Lab. 53(6), 377–381 (2017)CrossRef
15.
go back to reference C.C. Epitácio-Pereira, G.M. Silva, R. Salvatori, J.A. Santana, F.A. Pereira, M.B. Gois-Junior, A.V. Britto, C.R. Oliveira, A.H. Souza, E.G. Santos, V.C. Campos, R.M. Pereira, E.H. Valença, R.A. Barbosa, M.I. Farias, F.J. de Paula, T.V. Ribeiro, M.C. Oliveira, M.H. Aguiar-Oliveira, Isolated GH deficiency due to a GHRH receptor mutation causes hip joint problems and genu valgum, and reduces size but not density of trabecular and mixed bone. J. Clin. Endocrinol. Metab. 98(11), E1710–E1715 (2013)CrossRef C.C. Epitácio-Pereira, G.M. Silva, R. Salvatori, J.A. Santana, F.A. Pereira, M.B. Gois-Junior, A.V. Britto, C.R. Oliveira, A.H. Souza, E.G. Santos, V.C. Campos, R.M. Pereira, E.H. Valença, R.A. Barbosa, M.I. Farias, F.J. de Paula, T.V. Ribeiro, M.C. Oliveira, M.H. Aguiar-Oliveira, Isolated GH deficiency due to a GHRH receptor mutation causes hip joint problems and genu valgum, and reduces size but not density of trabecular and mixed bone. J. Clin. Endocrinol. Metab. 98(11), E1710–E1715 (2013)CrossRef
16.
go back to reference G. Maziotti, S. Frara, A. Giustina, Pituitary diseases and bone. Endocr. Rev. 39(4), 440–488 (2018)CrossRef G. Maziotti, S. Frara, A. Giustina, Pituitary diseases and bone. Endocr. Rev. 39(4), 440–488 (2018)CrossRef
17.
go back to reference R.T. Hamza, A.I. Hamed, M.T. Sallam, Vitamin D status in prepubertal children with isolated idiopathic growth hormone deficiency: effect of growth hormone therapy. J. Invest. Med. 66(5), 1–8 (2018)CrossRef R.T. Hamza, A.I. Hamed, M.T. Sallam, Vitamin D status in prepubertal children with isolated idiopathic growth hormone deficiency: effect of growth hormone therapy. J. Invest. Med. 66(5), 1–8 (2018)CrossRef
18.
go back to reference M. Kužma, N. Binkle, A. Bednárová, Z. Killinger, P. Vaňuga, J. Payer, Trabecular bone score change differs with regard to 25 (OH) D levels in patients treated for adult-onset growth hormone deficiency. Endocr. Pract. 22(8), 951–958 (2016)CrossRef M. Kužma, N. Binkle, A. Bednárová, Z. Killinger, P. Vaňuga, J. Payer, Trabecular bone score change differs with regard to 25 (OH) D levels in patients treated for adult-onset growth hormone deficiency. Endocr. Pract. 22(8), 951–958 (2016)CrossRef
Metadata
Title
Sweat and vitamin D status in congenital, lifetime, untreated GH deficiency
Authors
Cynthia S. Barros-Oliveira
Roberto Salvatori
Jéssica S. S. dos Santos
Paula F. C. Santos
Alécia A. Oliveira-Santos
Cindi G. Marinho
Elenilde G. Santos
Ângela C. G. B. Leal
Viviane C. Campos
Nayra P. Damascena
Carla R. P. Oliveira
Manuel H. Aguiar-Oliveira
Publication date
01-09-2019
Publisher
Springer US
Published in
Endocrine / Issue 3/2019
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-019-01998-7

Other articles of this Issue 3/2019

Endocrine 3/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.